These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8337191)

  • 21. Measurement of utility.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S43-9. PubMed ID: 24964698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains.
    Schiffner R; Brunnberg S; Hohenleutner U; Stolz W; Landthaler M
    Br J Dermatol; 2002 Mar; 146(3):440-7. PubMed ID: 11952544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preference-based quality of life measures in people with visual impairment.
    Kymes SM; Lee BS
    Optom Vis Sci; 2007 Aug; 84(8):809-16. PubMed ID: 17700344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma.
    Juniper EF; Norman GR; Cox FM; Roberts JN
    Eur Respir J; 2001 Jul; 18(1):38-44. PubMed ID: 11510803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life--an introduction.
    Khanna D; Tsevat J
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S218-23. PubMed ID: 18095785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials.
    Ward MM; Guthrie LC
    Rheumatology (Oxford); 2017 Feb; 56(2):239-246. PubMed ID: 27789761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity and interpretation of preference-based measures of health-related quality of life.
    Lenert L; Kaplan RM
    Med Care; 2000 Sep; 38(9 Suppl):II138-50. PubMed ID: 10982099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.
    Ruchlin HS; Insinga RP
    Pharmacoeconomics; 2008; 26(11):925-35. PubMed ID: 18850762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Setting Dead at Zero: Applying Scale Properties to the QALY Model.
    Roudijk B; Donders ART; Stalmeier PFM
    Med Decis Making; 2018 Aug; 38(6):627-634. PubMed ID: 29629848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review.
    Herdman M; Cole A; Hoyle CK; Coles V; Carroll S; Devlin N
    Value Health; 2016; 19(2):255-66. PubMed ID: 27021761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility approach to measuring health-related quality of life.
    Torrance GW
    J Chronic Dis; 1987; 40(6):593-603. PubMed ID: 3298297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods and issues associated with the use of quality-adjusted life-years.
    Revicki DA; Lenderking WR
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):105-14. PubMed ID: 22280200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between health utility and psychometric health status measures.
    Revicki DA
    Med Care; 1992 May; 30(5 Suppl):MS274-82. PubMed ID: 1583939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Guirant L; Carlos F; Curiel D; Kanis JA; Borgström F; Svedbom A; Clark P
    Osteoporos Int; 2018 May; 29(5):1147-1154. PubMed ID: 29464277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.